Noriko Konishi

A novel<scp>JAK</scp>inhibitor<scp>JTE</scp>‐052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents

Atsuo Tanimoto, Yuichi Shinozaki, Yasuo Yamamoto et al. · Experimental Dermatology · 2017 · 60 citations · Full text

Medicine, Dermatology, Pharmacology +17

Discovery of a Tetrahydropyrimidin-2(1<i>H</i>)-one Derivative (TAK-442) as a Potent, Selective, and Orally Active Factor Xa Inhibitor

Takuya Fujimoto, Yasuhiro Imaeda, Noriko Konishi et al. · Journal of Medicinal Chemistry · 2010 · 54 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +7

Potent Dibasic GPIIb/IIIa Antagonists with Reduced Prolongation of Bleeding Time:  Synthesis and Pharmacological Evaluation of 2-Oxopiperazine Derivatives

Shuji Kitamura, Hideto Fukushi, Toshio Miyawaki et al. · Journal of Medicinal Chemistry · 2001 · 32 citations

Medicine, Medicinal Chemistry, Pharmacology +17

IgE Associated nephropathy in a patient with subcutaneous eosinophilic lymphoid granuloma (Kimura's disease)

Noriko Konishi, Tadao Tamura, Chuichi Kawai et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 1981 · 31 citations

Medicine, Immunology, Nephrology +11

Discovery of Imidazo[1,5-<i>c</i>]imidazol-3-ones: Weakly Basic, Orally Active Factor Xa Inhibitors

Yasuhiro Imaeda, Takanobu Kuroita, Hiroki Sakamoto et al. · Journal of Medicinal Chemistry · 2008 · 28 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8